Waldencast Acquisition Corp
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $849.76 million
- Book Value:
- Revenue TTM:
- $73.45 million
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Waldencast Acquisition Corp had its IPO on 2021-05-12 under the ticker symbol WALD.
The company operates in the Technology sector and Software-Application industry. Waldencast Acquisition Corp has a staff strength of 0 employees.
Shares of Waldencast Acquisition Corp opened at $7.35 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.04 - $8.07, and closed at $7.15.
This is a -3.64% slip from the previous day's closing price.
A total volume of 65,671 shares were traded at the close of the day’s session.
In the last one week, shares of Waldencast Acquisition Corp have slipped by -9.49%.
Waldencast Acquisition Corp's Key Ratios
Waldencast Acquisition Corp has a market cap of $849.76 million, indicating a price to book ratio of 3.3543 and a price to sales ratio of 13.474.
In the last 12-months Waldencast Acquisition Corp’s revenue was $73.45 million with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Waldencast Acquisition Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Waldencast Acquisition Corp’s operating margin was -29.46% while its return on assets stood at 0% with a return of equity of 0%.
In Q3, Waldencast Acquisition Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Waldencast Acquisition Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.18 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Waldencast Acquisition Corp’s profitability.
Waldencast Acquisition Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -57.7884. Its price to sales ratio in the trailing 12-months stood at 13.474.
Waldencast Acquisition Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- Total Liabilities
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Waldencast Acquisition Corp ended 2023 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.
Waldencast Acquisition Corp ended 2023 with $0 in deferred long-term liabilities, $0 in other current liabilities, in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Waldencast Acquisition Corp’s total current assets stands at $0 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.
In 2023, Waldencast Acquisition Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Waldencast Acquisition Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Waldencast Acquisition Corp stock is currently trading at $7.15 per share. It touched a 52-week high of $12.1 and a 52-week low of $12.1. Analysts tracking the stock have a 12-month average target price of $13.5.
Its 50-day moving average was $6.69 and 200-day moving average was $8.39 The short ratio stood at 15.13 indicating a short percent outstanding of 0%.
Around 6975.7% of the company’s stock are held by insiders while 2390.6% are held by institutions.
Frequently Asked Questions About Waldencast Acquisition Corp
Similar Industry Stocks (Software-Application)
Waldencast plc, a skincare company, develops, markets, and sells skin health products worldwide. The company offers approximately 200 cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians’ offices, spas, and aestheticians. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force; and through distribution partners. The company was founded in 1988 and is based in White Plains, New York.